Calcarb with D Interactions
There are 283 drugs known to interact with Calcarb with D (calcium / vitamin d), along with 11 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 17 are major, 222 are moderate, and 44 are minor.
- View all 283 medications that may interact with Calcarb with D
- View Calcarb with D alcohol/food interactions (2)
- View Calcarb with D disease interactions (11)
Most frequently checked interactions
View interaction reports for Calcarb with D (calcium / vitamin d) and the medicines listed below.
- Abilify (aripiprazole)
- acetaminophen
- albuterol
- alendronate
- amlodipine
- aspirin
- atenolol
- bupropion
- cetirizine
- citalopram
- Colace (docusate)
- Diovan (valsartan)
- docusate
- ferrous sulfate
- furosemide
- gabapentin
- Lipitor (atorvastatin)
- lisinopril
- loratadine
- Lyrica (pregabalin)
- multivitamin
- Nexium (esomeprazole)
- omeprazole
- oxycodone
- simvastatin
- Synthroid (levothyroxine)
- Tylenol (acetaminophen)
- Vitamin B12 (cyanocobalamin)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
Calcarb with D alcohol/food interactions
There are 2 alcohol/food interactions with Calcarb with D (calcium / vitamin d).
Calcarb with D disease interactions
There are 11 disease interactions with Calcarb with D (calcium / vitamin d) which include:
- cardiovascular adverse effects
- phosphate calcifications
- cardiac contraction/conduction
- malabsorption
- renal dysfunction
- sarcoidosis
- arrhythmia
- electrolyte imbalance
- hypercalcemia
- renal dysfunction
- hepatobiliary dysfunction
Report options
QR code containing a link to this page
More about Calcarb with D (calcium / vitamin d)
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.